Rebecca A Hubbard, Ph.D.

faculty photo
Associate Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
Department: Biostatistics and Epidemiology

Contact information
Department of Biostatistics, Epidemiology & Informatics
University of Pennsylvania School of Medicine
604 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104
Office: 215-898-3311
Fax: 215-573-4865
Education:
B.S. (Ecology & Evolution, summa cum laude)
University of Pittsburgh, Pittsburgh, PA, 1999.
M.Sc. (Epidemiology)
University of Edinburgh, Edinburgh, UK, 2001.
M.Sc. (Applied Statistics, with honors)
Oxford University, Oxford, UK, 2002.
Ph.D. (Biostatistics)
University of Washington, Seattle, WA , 2007.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Dr. Hubbard's research focuses on development and application of statistical methodology for studies using observational data from community medical practice. This work encompasses evaluation of screening and diagnostic test performance, methods for comparative effectiveness studies, and health services research. A wealth of data on healthcare utilization, performance, and outcomes are available from electronic medical records. However, the complex observation scheme giving rise to these data necessitates careful study design and analysis to ensure that inference is valid. Dr. Hubbard’s methodological research emphasizes development of statistical tools for such inference and has been applied to studies of cancer screening, aging and dementia, pharmacoepidemiology, women’s health, and behavioral health.

Selected Publications

Noe MH, Rosenbach M, Hubbard RA, Cardones ARG, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG: Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis— ABCD-10. JAMA Dermatology 155(4): 448-454, March 2019.

Chen Y, Wang J, Chubak J, Hubbard RA: Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence. Pharmacoepidemiology & Drug Safety 28(2): 264-268, February 2019.

Noe M, Shin DB, Hubbard RA, Hennessy S, Gelfand JM: Influenza vaccination rates in adults with psoriasis compared to adults with other chronic diseases. Journal of Investigative Dermatology 139(2): 473-475, February 2019.

Demissei BG, Finkelman B, Hubbard RA, Smith AM, Narayan HK, Narayan V, Shah P, Waxman AJ, Domchek SM, Ky B : Cardiovascular function phenotypes in response to cardiotoxic breast cancer therapy. Journal of the American College of Cardiology 73(2): 246-249, February 2019.

Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, Willis AW: Patterns of dementia treatment and frank prescribing errors in Parkinson disease. JAMA Neurology 76(1): 41-49, January 2019.

Hubbard RA, Huang J, Harton J, Oganisian A, Choi G, Utidjian L, Eneli I, Bailey LC, Chen Y: A Bayesian latent class approach for EHR-based phenotyping. Statistics in Medicine 38: 74-87, January 2019.

Greenblatt R, Zhao E, Henrickson S, Apter A, Hubbard RA, Himes BE: Factors associated with exacerbations among adults with asthma according to EHR data. Asthma Research and Practice 5(1), January 2019.

Pocobelli G, Yu O, Ziebell RA, Bowles EJA, Fujii MM, Sterret AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak JC: Use of antidepressants after colon cancer diagnosis and risk of recurrence. Psycho-Oncology January 2019 Notes: [epub ahead of print, DOI:10.1002/pon.5015]

Bowles EJA, Yu O, Ziebell R, Chen L, Boudreau D, Ritzwoller DP, Hubbard RA, Boggs J, Burnett-Hartman A, Sterrett A, Fujii M, Chubak J: Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study. BMC Cancer In press, 2019.

Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V on behalf of the ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ working group: False-positive results in a population-based colorectal screening programme: cumulative risk over seven biennial FOBT screening rounds. Cancer Epidemiology, Biomarkers & Prevention In press, 2019.

back to top
Last updated: 05/23/2019
The Trustees of the University of Pennsylvania